Johnson & Johnson to Provide Webcast Presentation of Tapentadol Extended Release (ER) Phase 3 Clinical Data Presented at World Institute of Pain 5th Annual Worl... ( NEW BRUNSWICK N.J. March 12 /- .....)

HOME >> MEDICINE >> NEWS

Johnson & Johnson to Provide Webcast Presentation of Tapentadol Extended Release (ER) Phase 3 Clinical Data Presented at World Institute of Pain 5th Annual World Congress

Date:3/12/2009

NEW BRUNSWICK, N.J., March 12 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will provide a pre-recorded webcast for financial analysts on Sunday, March 15 at 10:00 a.m. (Eastern Time) to coincide with the World Institute of Pain 5th World Congress (WIP) in New York City. Phase 3 clinical data on investigational tapentadol extended release (ER), a novel centrally acting oral analgesic, will be presented for the first time in a poster session at WIP.

A pre-recorded Webcast, with the lead tapentadol researchers, will be made available concurrent to the data presentations being made during the poster session at WIP. Pre-registration is not required to view the webcast/podcast.

The presentation will provide an overview on tapentadol and review data from the following clinical posters:

Efficacy and Safety of Tapentadol Extended Release (ER) for Chronic Pain Due to Osteoarthritis of the Knee: Results of a Phase 3 Study

Efficacy and Gastrointestinal Tolerability of Tapentadol Extended Release in a Randomized, Double-Blind, Placebo- and Active-Controlled Study in Patients With Moderate-to-Severe Chronic Osteoarthritis Knee Pain

The webcast/podcast and replay can be accessed by clicking on "Webcasts/Presentations" in the Investor Relations section of the Company's website at http://www.jnj.com.

0

GOOD

Page: 1
Related medicine news :

1. Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference
2. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
3. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
4. Trust for Americas Health Receives $7.6 Million Grant from the Robert Wood Johnson Foundation to Advance the Quality and Impact of the Public Health System
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Johnson & Johnson Tops Annual Pharmaceutical Company Rankings in a New Report From Industry-Leading Publication Scrip
7. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
8. Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Professionals
9. Robert Wood Johnson Foundation Announces $15.6 Million Grant to Apply Power of the Archimedes Model to Critical Health Care Decisions
10. UAN Mourns Passing of President Cheryl L. Johnson, RN
11. Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate

Post Your Comments:

Johnson & Johnson to Provide Webcast Presentation of Tapentadol Extended Release (ER) Phase 3 Clinical Data Presented at World Institute of Pain 5th Annual Worl...( NEW BRUNSWICK N.J. March 12 /- .....),Health